Teva Pharmaceutical Industries Limited (GETTEX:TEV) Financings
Financings
| Raise | Date |
|---|---|
| Senior notes Announced: about US$4.9B Use of proceeds: Redeem certain existing notes, pay related fees and expenses, and general corporate purposes including repaying outstanding debt | Sep 10, 2026 |
| Senior notes (EUR and USD-denominated) Made bigger: about US$2.3B Use of proceeds: Fund tender offers for existing senior notes, pay related fees and expenses, and repay other outstanding debt | May 20, 2025 |
| Debt securities Announced: debt Use of proceeds: To fund, with cash on hand, the purchase price of notes bought back in the debt tender offers | May 19, 2025 |